脑部放疗,上午比下午敏感许多!
7 X0 ^* q# {4 L* K6 F* S( u6 V- F5 X& W* f: Q$ W$ h/ k
* \' g9 I! l+ V7 w
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.2 ^8 g2 ]+ f9 {) |" X S
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?6 a2 x2 X4 K& d/ x1 [, J
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.6 s& |7 t1 p2 u& ^& }: F
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.; ~( H5 ?. l3 i7 r$ c) F2 `) G( V
' n1 J7 K$ ^3 n+ kAbstract
( @/ w5 z0 k% a9 S/ f+ aBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
8 Y3 A& ?1 G8 O' D+ J( Q, k# H; _+ H5 x
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
6 v q* P" r5 _, v
; A: ?; N: h4 ~. V, \, I+ bRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)." z$ }6 V& `) C- ~1 d
6 o$ a! U+ z& N" h+ O2 i
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.( x) H) ^3 h4 w# T5 r# n$ n
" {: w" K+ c# L; t" }3 w |